Literature DB >> 167965

Human neuroblastoma in nude mice.

L Helson, S K Das, S I Hajdu.   

Abstract

For establishment of a reproducible model of human neuroblastoma, 2 to 5 million of established neuroblastoma cell lines (SK-N-SH, SK-N-MC) were injected s.c. or i.p. into 20 nu/nu mice of a predominantly Swiss back-ground. Following latency periods of 8 to 21 days, tumors developed at the injection site and grew to 4-ml volumes within 3 weeks. Histologically, the tumors resembled the original metastases from which the tumors were derived; however, the SK-N-SH appeared to have evidence of morphological differentiation. When compared to monolayer culture, the heterotransplanted SK-N-SH tumor had decreased dopamine-beta-hydroxylase activity and elevated cyclic adenosine 3':5'-monophosphate phosphodiesterase activity. Activity of cyclic adenosine 3':5'-monophosphate phosphodiesterase in the transplanted SK-N-MC tumor was not appreciably different from the activity in the cultured cells. Serum dopamine-beta-hydroxylase levels in the mice bearing SK-N-SH tumor increased threefold. The SK-N-MC cultured cells lacked dopamine-beta-hydroxylase and did not alter existing serum levels in the SK-N-MC tumor-bearing mice. 67Ga injected i.v. was found to localize in the tumor after 24 hr. Human neuroblastoma in the nude mouse can be a reproducible and informative model for tumor pharmacology, screening, radionuclides, tumor localization and imaging, and investigating morphological differentiation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167965

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  A novel xenograft model with intrinsic vascularisation for growing undifferentiated pleomorphic sarcoma NOS in mice.

Authors:  Daniel-Johannes Tilkorn; Adrien Daigeler; Joerg Hauser; Andrej Ring; Ingo Stricker; Inge Schmitz; Lars Steinstraesser; Hans-Ulrich Steinau; Sammy Al-Benna
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-07       Impact factor: 4.553

2.  Cultured Cell Line Models of Neuronal Differentiation: NT2, PC12, and SK-N-MC.

Authors:  Nune Darbinian
Journal:  Methods Mol Biol       Date:  2021

3.  [Heterotransplantation of malignant tumors of the head and neck to thymusaplastic "nude" mice (author's transl)].

Authors:  J Lindenberger; U Ganzer; H P Fortmeyer
Journal:  Arch Otorhinolaryngol       Date:  1978-03-03

4.  Magnetic resonance imaging for the evaluation of a novel metastatic orthotopic model of human neuroblastoma in immunodeficient mice.

Authors:  R Moats; L Q Ma; R Wajed; Y Sugiura; A Lazaryev; M Tyszka; R Jacobs; S Fraser; M D Nelson; Y A DeClerck
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Animal models of extracranial pediatric solid tumors.

Authors:  Guido Seitz; Sorin Armeanu-Ebinger; Steven Warmann; Jörg Fuchs
Journal:  Oncol Lett       Date:  2012-08-06       Impact factor: 2.967

6.  In vitro and in vivo inhibition of SK-N-MC neuroblastoma growth using cyclic nucleotide phosphodiesterase inhibitors.

Authors:  M Giorgi; C Leonetti; G Citro; G Augusti-Tocco
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

7.  Anti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastoma.

Authors:  Richard Y Zhao; Dong Liang; Ge Li; Christopher W Larrimore; Bernard L Mirkin
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

8.  Oligosaccharides on living human neuroblastoma cells of dissimilar degrees of differentiation. A flow-cytometric study with sugar-specific lectins and glycosidases.

Authors:  B Pepperl; B Bohn; A Sauer; R Brossmer
Journal:  Cell Biophys       Date:  1993 Aug-Dec

9.  Influence of antipsychotic drugs on human endogenous retrovirus (HERV) transcription in brain cells.

Authors:  Olivia Diem; Marisa Schäffner; Wolfgang Seifarth; Christine Leib-Mösch
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

10.  A reproducible brain tumour model established from human glioblastoma biopsies.

Authors:  Jian Wang; Hrvoje Miletic; Per Ø Sakariassen; Peter C Huszthy; Hege Jacobsen; Narve Brekkå; Xingang Li; Peng Zhao; Sverre Mørk; Martha Chekenya; Rolf Bjerkvig; Per Ø Enger
Journal:  BMC Cancer       Date:  2009-12-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.